 |
|
|
|
|
| |
About Us
Company Profile
Directions |
KENNETH C. LEWIS, Ph.D.
CEO, OpAns LLC
Ken Lewis co-founded OpAns, a contract analytical services and software company serving the pre-clinical therapeutic drug discovery market, in 2004 with Joe Simpkins. As CEO, Dr. Lewis leads the management of laboratory operations providing LC-DAD-ELSD-CLND-MS, logD, solubility, chemical and microsomal stability, metabolite ID, in-vivo quantification and sales.
Dr. Lewis’ extensive background optimizing analytical chemistry for drug discovery prepared him to launch OpAns . He served in research scientist/investigator roles, as well as research advisor, for GlaxoWellcome and Lilly Research Labs, both in North Carolina’s Research Triangle Park. His leadership, management and vision led to the creation of new software and lab processes.
As research advisor at Lilly, Dr. Lewis integrated analytical chemistry into lead generation by supporting chemistry, biology, compound handling, and screening. His leadership and vision lead to a three-fold growth in staff, while leveraging productivity gains to improve the efficiency and effectiveness of lead generation.
He has led software development projects for the automatic reduction of analytical data and for interpreting, posting and retrieving analytical data.
Dr. Lewis was a post-doctoral fellow at Affymax Research Institute in Palo Alto, California. He earned a bachelor’s of science degree from Mercer University in Georgia and his Ph.D. in analytical chemistry from the University of North Carolina at Chapel Hill.
|
|
|
